Webinar Information

Interpreting Hemochromatosis

Hemochromatosis is a genetic condition that impairs the regulation of intestinal iron absorption, leading to an increased deposition of iron within the parenchymal tissues of the liver, heart and pancreas. Between 1 in 150 and 1 in 200 Australians of northern European descent are affected, with an estimated annual cost of $274 million. Early diagnosis and treatment of hemochromatosis usually results in minimal long term adverse effects and does not seem to have a significant impact on life expectancy. If undiagnosed, or improperly managed, hemochromatosis can lead to considerable tissue damage to the liver, heart and pancreas.

Complementary medicine practitioners are likely to encounter patients with hemochromatosis in their clinic. One of the most common strategies employed by clinicians is based around dietary recommendations to minimize iron consumption, however many clinicians may not realize that there are a range of other evidence-based strategies that can be utilized to achieve optima health outcomes for their patient’s.

This free webinar will provide clinicians with;

1. A better understanding of the aetiology, pathophysiology and clinical management of hemochromatosis.
2. Useful clinical tips in the assessment of a patient’s iron status.
3. Information about interpreting patient’s pathology test results.
4. Dietary management strategies to better regulate iron status.
5. A review of nutritional and herbal therapeutic interventions.